Literature DB >> 22146869

Whole-body MRI in neurofibromatosis: incidental findings and prevalence of scoliosis.

Jacob L Jaremko1, Peter J MacMahon, Martin Torriani, Vanessa L Merker, Victor F Mautner, Scott R Plotkin, Miriam A Bredella.   

Abstract

OBJECTIVE: To demonstrate incidental findings and scoliosis on whole-body MRI (WBMRI) in patients with neurofibromatosis type 1 and 2 (NF1 & NF2, respectively), and schwannomatosis.
MATERIALS AND METHODS: Institutional review board approval and written informed consent were obtained for this prospective HIPAA-compliant study. A total of 247 subjects (141 with NF1, 55 with NF2, 51 with schwannomatosis; 132 women (53.5%); mean age, 41 years, range, 18-97 years) underwent WBMRI using coronal STIR (TR/TE: 4190/111 ms, TI: 150 ms) and T1-weighted images (TR/TE: 454/10 ms), 10-mm slice thickness, imaging time ~40 min. Images were reviewed for the presence of incidental findings, outside of nerve sheath tumors. The presence of scoliosis was recorded and curve morphology was assessed and quantified.
RESULTS: Incidental findings other than scoliosis were recorded in 104/247 (42%) patients, most often affecting the musculoskeletal system (65/247 patients, 26%). We found 16/247 (6.5%) significant incidental findings likely to affect clinical management, including avascular necrosis of bone in eight patients (five with NF2), eight insufficiency fractures, and four non-neurogenic neoplasms (Hodgkin's lymphoma, liposarcoma, dermoid cyst, large uterine myoma requiring excision). Scoliosis was seen in 50/247 patients (20%), including 8/55 with NF2 (15%) and 11/51 with schwannomatosis (22%).
CONCLUSIONS: Incidental findings in the neurofibromatoses frequently involve the skeleton. Given the relatively high incidence of unsuspected osteonecrosis and stress fractures, close attention to the skeleton on WBMRI is advised. In addition, knowledge of common incidental findings can help clinicians prepare patients who undergo WBMRI for potential unexpected findings.

Entities:  

Mesh:

Year:  2011        PMID: 22146869     DOI: 10.1007/s00256-011-1333-x

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  22 in total

1.  Dystrophic spinal deformity in neurofibromatosis.

Authors:  J L Sirois; J C Drennan
Journal:  J Pediatr Orthop       Date:  1990 Jul-Aug       Impact factor: 2.324

Review 2.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

Authors:  D H Gutmann; A Aylsworth; J C Carey; B Korf; J Marks; R E Pyeritz; A Rubenstein; D Viskochil
Journal:  JAMA       Date:  1997-07-02       Impact factor: 56.272

3.  Comparison of Cobb angles in idiopathic scoliosis on standing radiographs and supine axially loaded MRI.

Authors:  Per Wessberg; Barbro I Danielson; Jan Willén
Journal:  Spine (Phila Pa 1976)       Date:  2006-12-15       Impact factor: 3.468

4.  Bone development in neurofibromatosis 1.

Authors:  M E Abdel-Wanis; N Kawahara
Journal:  Med Hypotheses       Date:  2003-04       Impact factor: 1.538

Review 5.  Scoliosis associated with neurofibromatosis.

Authors:  Alvin H Crawford; Jose Herrera-Soto
Journal:  Orthop Clin North Am       Date:  2007-10       Impact factor: 2.472

6.  Bone health and fracture rate in individuals with neurofibromatosis 1 (NF1).

Authors:  T Tucker; C Schnabel; M Hartmann; R E Friedrich; I Frieling; H-P Kruse; V-F Mautner; J M Friedman
Journal:  J Med Genet       Date:  2008-12-09       Impact factor: 6.318

7.  Tumor burden in patients with neurofibromatosis types 1 and 2 and schwannomatosis: determination on whole-body MR images.

Authors:  Wenli Cai; Ara Kassarjian; Miriam A Bredella; Gordon J Harris; Hiroyuki Yoshida; Victor F Mautner; Ralph Wenzel; Scott R Plotkin
Journal:  Radiology       Date:  2009-03       Impact factor: 11.105

Review 8.  Clinical and genetic aspects of neurofibromatosis 1.

Authors:  Kimberly Jett; Jan M Friedman
Journal:  Genet Med       Date:  2010-01       Impact factor: 8.822

9.  The prevalence of incidental findings at cardiac MRI.

Authors:  David A McKenna; Monish Laxpati; Patrick M Colletti
Journal:  Open Cardiovasc Med J       Date:  2008-04-02

Review 10.  The Neurofibromatoses. Part 1: NF1.

Authors:  Christine Lu-Emerson; Scott R Plotkin
Journal:  Rev Neurol Dis       Date:  2009
View more
  11 in total

1.  Frequency, distribution and clinical management of incidental findings and extramedullary plasmacytomas in whole body diffusion weighted magnetic resonance imaging in patients with multiple myeloma.

Authors:  Anita Wale; Charlotte Pawlyn; Martin Kaiser; Christina Messiou
Journal:  Haematologica       Date:  2016-01-27       Impact factor: 9.941

Review 2.  Coincident liposarcoma, carcinoid and gastrointestinal stromal tumor complicating type 1 neurofibromatosis: Case report and literature review.

Authors:  Aaron W James; Le Chang; Scott Genshaft; Sarah M Dry
Journal:  J Orthop       Date:  2014-11-26

Review 3.  Current status and recommendations for imaging in neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis.

Authors:  Shivani Ahlawat; Jaishri O Blakeley; Shannon Langmead; Allan J Belzberg; Laura M Fayad
Journal:  Skeletal Radiol       Date:  2019-08-08       Impact factor: 2.199

4.  Neurofibromatosis Type 1 With Cherubism-like Phenotype, Multiple Osteolytic Bone Lesions of Lower Extremities, and Alagille-syndrome: Case Report With Literature Survey.

Authors:  Reinhard E Friedrich; Jozef Zustin; Andreas M Luebke; Thorsten Rosenbaum; Martin Gosau; Christian Hagel; Felix K Kohlrusch; Ilse Wieland; Martin Zenker
Journal:  In Vivo       Date:  2021 May-Jun       Impact factor: 2.155

5.  Widespread osteonecrosis in children with leukemia revealed by whole-body MRI.

Authors:  Paivi Maria Miettunen; Lucie Lafay-Cousin; Gregory M T Guilcher; Alberto Nettel-Aguirre; Vijay Moorjani
Journal:  Clin Orthop Relat Res       Date:  2012-09-25       Impact factor: 4.176

6.  Conclusions and future directions for the REiNS International Collaboration.

Authors:  Brigitte C Widemann; Jaishri O Blakeley; Eva Dombi; Michael J Fisher; Clemens O Hanemann; Karin S Walsh; Pamela L Wolters; Scott R Plotkin
Journal:  Neurology       Date:  2013-11-19       Impact factor: 9.910

7.  Whole-body magnetic resonance imaging (WB-MRI) with diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) in prostate cancer: Prevalence and clinical significance of incidental findings.

Authors:  Soma Kumasaka; Shunichi Motegi; Yuka Kumasaka; Tatsuya Nishikata; Masami Otomo; Yoshito Tsushima
Journal:  Br J Radiol       Date:  2021-06-16       Impact factor: 3.039

8.  Current whole-body MRI applications in the neurofibromatoses: NF1, NF2, and schwannomatosis.

Authors:  Shivani Ahlawat; Laura M Fayad; Muhammad Shayan Khan; Miriam A Bredella; Gordon J Harris; D Gareth Evans; Said Farschtschi; Michael A Jacobs; Avneesh Chhabra; Johannes M Salamon; Ralph Wenzel; Victor F Mautner; Eva Dombi; Wenli Cai; Scott R Plotkin; Jaishri O Blakeley
Journal:  Neurology       Date:  2016-08-16       Impact factor: 9.910

9.  Multiparametric whole-body anatomic, functional, and metabolic imaging characteristics of peripheral lesions in patients with schwannomatosis.

Authors:  Shivani Ahlawat; Asad Baig; Jaishri O Blakeley; Michael A Jacobs; Laura M Fayad
Journal:  J Magn Reson Imaging       Date:  2016-03-17       Impact factor: 5.119

10.  Whole Body MRI at 3T with Quantitative Diffusion Weighted Imaging and Contrast-Enhanced Sequences for the Characterization of Peripheral Lesions in Patients with Neurofibromatosis Type 2 and Schwannomatosis.

Authors:  Laura M Fayad; Jaishri Blakeley; Scott Plotkin; Brigitte Widemann; Michael A Jacobs
Journal:  ISRN Radiol       Date:  2013-10-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.